Paper46840
Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.
Budzko DB and 2 others. Infect Immun, 1975. Cited by 105 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi. Papers, record 46840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46840
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chagas Disease | Major topic |
| Complement System Proteins | Major topic |
| Trypanosoma cruzi | Major topic |
| Trypanosomiasis | Major topic |
| Animals | |
| Endotoxins | |
| Escherichia coli | |
| Humans | |
| Immune Sera | |
| Lectins | |
| Male | |
| Mice | |
| Snakes | |
| Venoms | |
| gamma-Globulins |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 3 | 4213449 | The immunology of experimental Chagas' disease. I. Preparation of Trypanosoma cruzi antigens and humoral antibody response to there antigens. | J Immunol | 1974 | https://conductscience.org/library/papers/4213449 | PubMed |
| 4 | 4361979 | Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi. | J Immunol | 1974 | https://conductscience.org/library/papers/4361979 | PubMed |
| 5 | 4564786 | Role of complement in immune lysis of Trypanosoma cruzi. | Infect Immun | 1972 | https://conductscience.org/library/papers/4564786 | PubMed |
| 6 | 4627510 | C3 shunt activation in human serum chelated with EGTA. | J Immunol | 1972 | https://conductscience.org/library/papers/4627510 | PubMed |
| 7 | 4629840 | The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi. | J Protozool | 1972 | https://conductscience.org/library/papers/4629840 | PubMed |
| 8 | 4983548 | [Sensitivity of serological tests in the diagnosis of Chagas' disease]. | Bol Chil Parasitol | 1969 | https://conductscience.org/library/papers/4983548 | PubMed |
| 9 | 5120401 | Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. | J Immunol | 1971 | https://conductscience.org/library/papers/5120401 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28919885 | Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28919885 | PubMed |
| 26745156 | Genetically Determined MBL Deficiency Is Associated with Protection against Chronic Cardiomyopathy in Chagas Disease. | PLoS Negl Trop Dis | 2016 | https://conductscience.org/library/papers/26745156 | PubMed |
| 20625554 | Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. | PLoS Negl Trop Dis | 2010 | https://conductscience.org/library/papers/20625554 | PubMed |
| 20037731 | Improved method for in vitro secondary amastigogenesis of Trypanosoma cruzi: morphometrical and molecular analysis of intermediate developmental forms. | J Biomed Biotechnol | 2010 | https://conductscience.org/library/papers/20037731 | PubMed |
| 10194457 | Chagas' disease and the autoimmunity hypothesis. | Clin Microbiol Rev | 1999 | https://conductscience.org/library/papers/10194457 | PubMed |
| 9596703 | Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. | Infect Immun | 1998 | https://conductscience.org/library/papers/9596703 | PubMed |
| 7873124 | Trypanosoma cruzi infection in rats induced early lesion of the heart noradrenergic nerve terminals by a complement-independent mechanism. | J Neural Transm Gen Sect | 1994 | https://conductscience.org/library/papers/7873124 | PubMed |
| 6797951 | Induction of the acute-phase protein serum amyloid P in experimental Chagas' disease. | Infect Immun | 1982 | https://conductscience.org/library/papers/6797951 | PubMed |
| 6793386 | Immune T cells control Trypanosoma cruzi infections. | Experientia | 1981 | https://conductscience.org/library/papers/6793386 | PubMed |
| 6772558 | Experimental Chagas' disease in complement-deficient mice and guinea pigs. | Infect Immun | 1980 | https://conductscience.org/library/papers/6772558 | PubMed |
| 6772557 | Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells. | Infect Immun | 1980 | https://conductscience.org/library/papers/6772557 | PubMed |
| 6698607 | Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis. | Infect Immun | 1984 | https://conductscience.org/library/papers/6698607 | PubMed |
| 6454138 | Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6454138 | PubMed |
| 6421519 | Isotype of lytic antibodies in serum of Chagas' disease patients. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6421519 | PubMed |
| 3926649 | Trypanolytic activity, agglutinins, and opsonins in sera from animals refractory to Trypanosoma lewisi. | Infect Immun | 1985 | https://conductscience.org/library/papers/3926649 | PubMed |
| 3910312 | Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/3910312 | PubMed |
| 3653986 | Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis. | Infect Immun | 1987 | https://conductscience.org/library/papers/3653986 | PubMed |
| 3143107 | A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection. | Parasitol Res | 1988 | https://conductscience.org/library/papers/3143107 | PubMed |
| 2663722 | Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies. | Infect Immun | 1989 | https://conductscience.org/library/papers/2663722 | PubMed |
| 2104596 | Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis. | Infect Immun | 1990 | https://conductscience.org/library/papers/2104596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46840
GET https://conductscience.org/api/papers/v1/46840/cited_by?page=2